The Council for Healthcare Regulatory Excellence (CHRE) is the overarching, independent body overseeing the work of healthcare professional regulatory bodies across the United Kingdom.

Each year the CHRE carry out a performance review of the regulatory bodies and report their findings to Parliament. 

As part of this year's review, the CHRE are seeking the views of third party stakeholders and would like to hear about the experiences individuals may have had with the Pharmaceutical Society of Northern Ireland in 2011.

We encourage interested parties and stakeholders to respond to the invitation for third party feedback via the CHRE website by 16 December 2011